Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Search by expertise, name or affiliation
Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?
Takemori Yamawaki, Norihiro Suzuki
Department of Internal Medicine
Contribution to journal
Dive into the research topics of 'Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?'. Together they form a unique fingerprint.
Medicine & Life Sciences
Adrenal Cortex Hormones
Miller Fisher Syndrome
Chronic Inflammatory Demyelinating Polyradiculoneuropathy